William Blair Investment Management
TEVA icon

William Blair Investment Management’s Teva Pharmaceuticals TEVA Stock Holding History

William Blair Investment Management’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$42.9M Buy
+1,425,667
New +$45.9M 0.14% 149
2025
Q1 		– Sell
-4,241,547
Closed -$93.5M – 456
2024
Q4 		$93.5M Sell
4,241,547
-105,451
-2% -$1.92M 0.23% 118
2024
Q3 		$78.3M Buy
+4,346,998
New +$76.1M 0.19% 119
2016
Q3 		– Sell
-3,357,060
Closed -$169M – 467
2016
Q2 		$169M Sell
3,357,060
-1,770,847
-35% -$94.3M 0.67% 50
2016
Q1 		$274M Sell
5,127,907
-1,123,083
-18% -$65.9M 1.09% 12
2015
Q4 		$410M Buy
6,250,990
+729,749
+13% +$45.1M 1.66% 3
2015
Q3 		$312M Buy
+5,521,241
New +$358M 0.64% 10

Other funds holding TEVA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

William Blair Investment Management's TEVA Position: Q1 2026 in Review

William Blair Investment Management opened a new position in Teva Pharmaceuticals (TEVA) in Q1 2026: 1,425,667 shares worth $42.9M. The stake represents 0.14% of the portfolio and ranks #149 among its holdings. This is a return to the name: William Blair Investment Management previously reported a position in TEVA as recently as Q4 2024.

William Blair Investment Management first reported a position in TEVA in Q3 2015 and has held it in 7 quarters since. The position peaked at $410M in Q4 2015. 651 funds tracked by Wall St. Rank hold TEVA as of Q1 2026.

  • William Blair Investment Management held 1,425,667 shares of Teva Pharmaceuticals worth $42.9M as of Q1 2026.
  • Teva Pharmaceuticals was a new William Blair Investment Management position in Q1 2026.
  • Teva Pharmaceuticals made up 0.14% of William Blair Investment Management's portfolio in Q1 2026, its #149 holding.
  • William Blair Investment Management first reported a position in Teva Pharmaceuticals in Q3 2015 and has held it in 7 quarters since.
  • William Blair Investment Management's Teva Pharmaceuticals position peaked at $410M in Q4 2015.
  • 651 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q1 2026.

Based on William Blair Investment Management's 13F filing for Q1 2026, filed 8 May 2026.